JC
JPMorgan Chase added $466M of MRNA stock
JPMorgan Chase added $466M of Moderna, Inc. (MRNA) stock in the quarter ending Sep 30, 2026, per a 13F filed Nov 12, 2026.
A 13F shows holdings at quarter end, so the exact trade dates are not disclosed.
- Disclosed
- Nov 12, 2026
- Quarter end
- Sep 30, 2026
- Source
- SEC Form 13F